Member Society Symposia

Cytokines and Interferons in Basic and Clinical Immunology: Reports from the International Cytokine & Interferon Society

Wednesday, June 14
8:00 AM - 12:00 PM

Sponsored By: 

Chair: Curt M. Horvath, PhD

This symposium will showcase a representative group of research presentations from members of the ICIS, from basic research to clinical application.

Agenda:
8:00 a.m. Welcome & Introductions
Curt M. Horvath, PhD, Northwestern University

8:10 a.m. Clinical Development of Cancer Immuno-therapeutics Iargeting Chemokine Receptors and T Cells
Kouji Matsushima, MD, PhD, University of Tokyo

8:35 a.m. The Pro-inflammatory Cytokine Response in Necrotizing Enterocolitis
Misty Good, MD, MS, Washington University

9:00 a.m. IL-17A Controls Expression of IL-17 Lineage Cytokines Through a Negative Feedback Loop Involving IL-24, and Limits Autoimmune Disease
Rachel R. Caspi, PhD, National Institutes of Health

9:25 a.m. Description of the IFN Receptor Pathway Signaling and Its Relevance to Cancer
Leonidas C. Platanias, MD, PhD, Northwestern University

10:00 a.m. Coffee Break

10:30 a.m. Highly Dysregulated Type I IFN System in Multiple Sclerosis
Anthony T. Reder, MD, University of Chicago

10:55 a.m. Specific Detection of IFNα and IFNβ Signaling Complexes on Human Cells
Mark R. Walter, PhD, University of Alabama at Birmingham

11:20 a.m. Negative Regulation of Type I IFN Signaling by Phosphorylation of STAT2 on T387
Yuxin Wang, PhD, Cleveland Clinic Foundation

11:45 a.m. Closing Remarks

For more information about the International Cytokine & Interferon Society, please visit www.cytokinesociety.org.

Learning Objectives:


Assets

Cytokines and Interferons in Basic and Clinical Immunology: Reports from the International Cytokine & Interferon Society



Attendees who have favorited this

Send Email for Cytokines and Interferons in Basic and Clinical Immunology: Reports from the International Cytokine & Interferon Society